SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 120,445.08 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 78,042.00 |
| Book Value / Share | 62.25 |
| Price / Book | n/a |
| NCAV ($M) | -12,353.00 |
| NCAV / Share | -9.85 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.06 |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | 0.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.14 |
| Current Ratio | 1.46 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 42,587.00 |
| Assets | 132,982.00 |
| Liabilities | 54,940.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 44,286.00 |
| Operating Income | 9,068.00 |
| Net Income | 5,744.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 9,081.00 |
| Cash from Investing | -4,407.00 |
| Cash from Financing | -5,763.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| SMFL – Smart for Life, Inc. | SNNC – Sibannac, Inc. |
| SNPHF – Santen Pharmaceutical Co., Ltd. | SPHDF – Santhera Pharmaceuticals Holding AG |
| SQZB – SQZ Biotechnologies Company |
Financial data and stock pages provided by
Fintel.io